A citation-based method for searching scientific literature

J B Penney, J P Vonsattel, M E MacDonald, J F Gusella, R H Myers. Ann Neurol 1997
Times Cited: 478







List of co-cited articles
583 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data.
Sarah J Tabrizi, Douglas R Langbehn, Blair R Leavitt, Raymund Ac Roos, Alexandra Durr, David Craufurd, Christopher Kennard, Stephen L Hicks, Nick C Fox, Rachael I Scahill,[...]. Lancet Neurol 2009
644
46

Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
Sarah J Tabrizi, Rachael I Scahill, Gail Owen, Alexandra Durr, Blair R Leavitt, Raymund A Roos, Beth Borowsky, Bernhard Landwehrmeyer, Chris Frost, Hans Johnson,[...]. Lancet Neurol 2013
496
34


Huntington disease: natural history, biomarkers and prospects for therapeutics.
Christopher A Ross, Elizabeth H Aylward, Edward J Wild, Douglas R Langbehn, Jeffrey D Long, John H Warner, Rachael I Scahill, Blair R Leavitt, Julie C Stout, Jane S Paulsen,[...]. Nat Rev Neurol 2014
542
23

Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
Sarah J Tabrizi, Ralf Reilmann, Raymund A C Roos, Alexandra Durr, Blair Leavitt, Gail Owen, Rebecca Jones, Hans Johnson, David Craufurd, Stephen L Hicks,[...]. Lancet Neurol 2012
358
20

Detection of Huntington's disease decades before diagnosis: the Predict-HD study.
J S Paulsen, D R Langbehn, J C Stout, E Aylward, C A Ross, M Nance, M Guttman, S Johnson, M MacDonald, L J Beglinger,[...]. J Neurol Neurosurg Psychiatry 2008
544
19

Huntington's disease.
Francis O Walker. Lancet 2007
19

Huntington disease: clinical care and evaluation.
I Shoulson, S Fahn. Neurology 1979
563
19

Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis.
Sarah J Tabrizi, Rachael I Scahill, Alexandra Durr, Raymund Ac Roos, Blair R Leavitt, Rebecca Jones, G Bernhard Landwehrmeyer, Nick C Fox, Hans Johnson, Stephen L Hicks,[...]. Lancet Neurol 2011
387
16

Huntington's disease: from molecular pathogenesis to clinical treatment.
Christopher A Ross, Sarah J Tabrizi. Lancet Neurol 2011
920
14

Neuropathological classification of Huntington's disease.
J P Vonsattel, R H Myers, T J Stevens, R J Ferrante, E D Bird, E P Richardson. J Neuropathol Exp Neurol 1985
14

Huntington disease.
Gillian P Bates, Ray Dorsey, James F Gusella, Michael R Hayden, Chris Kay, Blair R Leavitt, Martha Nance, Christopher A Ross, Rachael I Scahill, Ronald Wetzel,[...]. Nat Rev Dis Primers 2015
598
14

Neurocognitive signs in prodromal Huntington disease.
Julie C Stout, Jane S Paulsen, Sarah Queller, Andrea C Solomon, Kathryn B Whitlock, J Colin Campbell, Noelle Carlozzi, Kevin Duff, Leigh J Beglinger, Douglas R Langbehn,[...]. Neuropsychology 2011
249
14

CAG-repeat length and the age of onset in Huntington disease (HD): a review and validation study of statistical approaches.
Douglas R Langbehn, Michael R Hayden, Jane S Paulsen. Am J Med Genet B Neuropsychiatr Genet 2010
208
13

Motor, cognitive, and functional declines contribute to a single progressive factor in early HD.
Scott A Schobel, Giuseppe Palermo, Peggy Auinger, Jeffrey D Long, Shiyang Ma, Omar S Khwaja, Dylan Trundell, Merit Cudkowicz, Steven Hersch, Cristina Sampaio,[...]. Neurology 2017
50
26

A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length.
D R Langbehn, R R Brinkman, D Falush, J S Paulsen, M R Hayden. Clin Genet 2004
529
12

Behavioral changes in Huntington Disease.
D Craufurd, J C Thompson, J S Snowden. Neuropsychiatry Neuropsychol Behav Neurol 2001
275
12

Indexing disease progression at study entry with individuals at-risk for Huntington disease.
Ying Zhang, Jeffrey D Long, James A Mills, John H Warner, Wenjing Lu, Jane S Paulsen. Am J Med Genet B Neuropsychiatr Genet 2011
146
12

Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity.
H Diana Rosas, David H Salat, Stephanie Y Lee, Alexandra K Zaleta, Vasanth Pappu, Bruce Fischl, Doug Greve, Nathanael Hevelone, Steven M Hersch. Brain 2008
323
11

Clinical and Biomarker Changes in Premanifest Huntington Disease Show Trial Feasibility: A Decade of the PREDICT-HD Study.
Jane S Paulsen, Jeffrey D Long, Hans J Johnson, Elizabeth H Aylward, Christopher A Ross, Janet K Williams, Martha A Nance, Cheryl J Erwin, Holly J Westervelt, Deborah L Harrington,[...]. Front Aging Neurosci 2014
136
11

Data Analytics from Enroll-HD, a Global Clinical Research Platform for Huntington's Disease.
Georg B Landwehrmeyer, Cheryl J Fitzer-Attas, Joseph D Giuliano, Nilza Gonçalves, Karen E Anderson, Francisco Cardoso, Joaquim J Ferreira, Tiago A Mestre, Julie C Stout, Cristina Sampaio. Mov Disord Clin Pract 2016
92
11

Neuropsychiatric symptoms are very common in premanifest and early stage Huntington's Disease.
Saul Martinez-Horta, Jesus Perez-Perez, Erik van Duijn, Ramon Fernandez-Bobadilla, Mar Carceller, Javier Pagonabarraga, Berta Pascual-Sedano, Antonia Campolongo, Jesus Ruiz-Idiago, Frederic Sampedro,[...]. Parkinsonism Relat Disord 2016
78
12

Diagnostic criteria for Huntington's disease based on natural history.
Ralf Reilmann, Blair R Leavitt, Christopher A Ross. Mov Disord 2014
105
10

Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington's disease.
Lauren M Byrne, Filipe B Rodrigues, Eileanor B Johnson, Peter A Wijeratne, Enrico De Vita, Daniel C Alexander, Giuseppe Palermo, Christian Czech, Scott Schobel, Rachael I Scahill,[...]. Sci Transl Med 2018
59
16

Regional cortical thinning in preclinical Huntington disease and its relationship to cognition.
H D Rosas, N D Hevelone, A K Zaleta, D N Greve, D H Salat, B Fischl. Neurology 2005
231
10

Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington's disease patients.
Edward J Wild, Roberto Boggio, Douglas Langbehn, Nicola Robertson, Salman Haider, James R C Miller, Henrik Zetterberg, Blair R Leavitt, Rainer Kuhn, Sarah J Tabrizi,[...]. J Clin Invest 2015
124
9

Huntington's disease: a clinical review.
P McColgan, S J Tabrizi. Eur J Neurol 2018
290
9

Cognitive decline in prodromal Huntington Disease: implications for clinical trials.
Jane S Paulsen, Megan M Smith, Jeffrey D Long. J Neurol Neurosurg Psychiatry 2013
67
13


Movement Disorder Society Task Force Viewpoint: Huntington's Disease Diagnostic Categories.
Christopher A Ross, Ralf Reilmann, Francisco Cardoso, Elizabeth A McCusker, Claudia M Testa, Julie C Stout, Blair R Leavitt, Zhong Pei, Bernhard Landwehrmeyer, Asuncion Martinez,[...]. Mov Disord Clin Pract 2019
26
34

HD-CAB: a cognitive assessment battery for clinical trials in Huntington's disease 1,2,3.
Julie C Stout, Sarah Queller, Kalyca N Baker, Sean Cowlishaw, Cristina Sampaio, Cheryl Fitzer-Attas, Beth Borowsky. Mov Disord 2014
50
16

Executive and mnemonic functions in early Huntington's disease.
A D Lawrence, B J Sahakian, J R Hodges, A E Rosser, K W Lange, T W Robbins. Brain 1996
283
8

Reliability and factor structure of the Short Problem Behaviors Assessment for Huntington's disease (PBA-s) in the TRACK-HD and REGISTRY studies.
Jenny Callaghan, Cheryl Stopford, Natalie Arran, Marie-Francoise Boisse, Allison Coleman, Rachelle Dar Santos, Eve M Dumas, Ellen P Hart, Damian Justo, Gail Owen,[...]. J Neuropsychiatry Clin Neurosci 2015
47
17

Cerebral cortex structure in prodromal Huntington disease.
Peggy C Nopoulos, Elizabeth H Aylward, Christopher A Ross, Hans J Johnson, Vincent A Magnotta, Andrew R Juhl, Ronald K Pierson, James Mills, Douglas R Langbehn, Jane S Paulsen. Neurobiol Dis 2010
95
8

Distribution of grey matter atrophy in Huntington's disease patients: a combined ROI-based and voxel-based morphometric study.
G Douaud, V Gaura, M-J Ribeiro, F Lethimonnier, R Maroy, C Verny, P Krystkowiak, P Damier, A-C Bachoud-Levi, P Hantraye,[...]. Neuroimage 2006
189
8

Striatal and white matter predictors of estimated diagnosis for Huntington disease.
Jane S Paulsen, Peggy C Nopoulos, Elizabeth Aylward, Christopher A Ross, Hans Johnson, Vincent A Magnotta, Andrew Juhl, Ronald K Pierson, James Mills, Douglas Langbehn,[...]. Brain Res Bull 2010
170
8

Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis.
Lauren M Byrne, Filipe B Rodrigues, Kaj Blennow, Alexandra Durr, Blair R Leavitt, Raymund A C Roos, Rachael I Scahill, Sarah J Tabrizi, Henrik Zetterberg, Douglas Langbehn,[...]. Lancet Neurol 2017
162
8

Cognitive and functional decline in Huntington's disease: dementia criteria revisited.
Guerry M Peavy, Mark W Jacobson, Jody L Goldstein, Joanne M Hamilton, Amy Kane, Anthony C Gamst, Stephanie L Lessig, J C Lee, Jody Corey-Bloom. Mov Disord 2010
67
11

Targeting Huntingtin Expression in Patients with Huntington's Disease.
Sarah J Tabrizi, Blair R Leavitt, G Bernhard Landwehrmeyer, Edward J Wild, Carsten Saft, Roger A Barker, Nick F Blair, David Craufurd, Josef Priller, Hugh Rickards,[...]. N Engl J Med 2019
287
8

The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease.
S E Andrew, Y P Goldberg, B Kremer, H Telenius, J Theilmann, S Adam, E Starr, F Squitieri, B Lin, M A Kalchman. Nat Genet 1993
805
7

Visuospatial Processing Deficits Linked to Posterior Brain Regions in Premanifest and Early Stage Huntington's Disease.
Izelle Labuschagne, Amy Mulick Cassidy, Rachael I Scahill, Eileanoir B Johnson, Elin Rees, Alison O'Regan, Sarah Queller, Chris Frost, Blair R Leavitt, Alexandra Dürr,[...]. J Int Neuropsychol Soc 2016
30
23

Huntington's disease (HD): the neuropathology of a multisystem neurodegenerative disorder of the human brain.
U Rüb, K Seidel, H Heinsen, J P Vonsattel, W F den Dunnen, H W Korf. Brain Pathol 2016
67
10

Compensation in Preclinical Huntington's Disease: Evidence From the Track-On HD Study.
Stefan Klöppel, Sarah Gregory, Elisa Scheller, Lora Minkova, Adeel Razi, Alexandra Durr, Raymund A C Roos, Blair R Leavitt, Marina Papoutsi, G Bernhard Landwehrmeyer,[...]. EBioMedicine 2015
81
8

Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study.
Jane S Paulsen, Jeffrey D Long, Christopher A Ross, Deborah L Harrington, Cheryl J Erwin, Janet K Williams, Holly James Westervelt, Hans J Johnson, Elizabeth H Aylward, Ying Zhang,[...]. Lancet Neurol 2014
143
7

Therapies targeting DNA and RNA in Huntington's disease.
Edward J Wild, Sarah J Tabrizi. Lancet Neurol 2017
137
7

Multi-modal neuroimaging in premanifest and early Huntington's disease: 18 month longitudinal data from the IMAGE-HD study.
Juan F Domínguez D, Gary F Egan, Marcus A Gray, Govinda R Poudel, Andrew Churchyard, Phyllis Chua, Julie C Stout, Nellie Georgiou-Karistianis. PLoS One 2013
60
11

Consistent neurodegeneration and its association with clinical progression in Huntington's disease: a coordinate-based meta-analysis.
Imis Dogan, Simon B Eickhoff, Jörg B Schulz, N Jon Shah, Angela R Laird, Peter T Fox, Kathrin Reetz. Neurodegener Dis 2013
50
14

Rating scales for cognition in Huntington's disease: Critique and recommendations.
Tiago A Mestre, Anne-Catherine Bachoud-Lévi, Johan Marinus, Julie C Stout, Jane S Paulsen, Peter Como, Kevin Duff, Cristina Sampaio, Christopher G Goetz, Esther Cubo,[...]. Mov Disord 2018
15
46

Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington's disease.
Julie C Stout, Rebecca Jones, Izelle Labuschagne, Alison M O'Regan, Miranda J Say, Eve M Dumas, Sarah Queller, Damian Justo, Rachelle Dar Santos, Allison Coleman,[...]. J Neurol Neurosurg Psychiatry 2012
92
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.